The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISAL 2019 | Epigenetic alleles: an emerging concept
Ari Melnick
• 25 Feb 2019
Discrete groups of cells in leukemia may have different transcriptomic properties, giving rise to the term ‘epigenetic alleles’. We spoke to Ari Melnick, MD, of Weill Cornell Medical College, New York, NY, about this fascinating emerging topic and its implications at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
